Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.78 USD | -4.81% | -10.10% | -40.86% |
May. 15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
May. 14 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
Financials (USD)
Sales 2024 * | 73.92M | Sales 2025 * | 126M | Capitalization | 37.24M |
---|---|---|---|---|---|
Net income 2024 * | -89M | Net income 2025 * | -75M | EV / Sales 2024 * | 0.5 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.3 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.56
x | Employees | 186 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.59% |
1 day | -4.81% | ||
1 week | -10.10% | ||
Current month | +6.59% | ||
1 month | +3.49% | ||
3 months | -18.35% | ||
6 months | -8.72% | ||
Current year | -40.86% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 09-09-30 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Weiss
BRD | Director/Board Member | 58 | 13-12-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 09-09-30 | |
Michael Weiss
BRD | Director/Board Member | 58 | 13-12-19 |
J. Lobell
BRD | Director/Board Member | 61 | 06-05-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 1.78 | -4.81% | 301,594 |
24-05-24 | 1.87 | +1.63% | 69,114 |
24-05-23 | 1.84 | -1.60% | 102,695 |
24-05-22 | 1.87 | -5.56% | 157,964 |
24-05-21 | 1.98 | +1.54% | 304,269 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.86% | 37.24M | |
-2.50% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
+61.28% | 26.41B | |
-22.81% | 14.34B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B |
- Stock Market
- Equities
- FBIO Stock